Clinical Trial Update: Haptoglobin Polymorphism as a Determinant of Adverse Outcome After Cardiac Surgery in Diabetic Patients

View source ↗

Summary

Clinical trial update noting completion of a study investigating whether haptoglobin polymorphism predicts adverse outcomes after cardiac surgery in diabetic pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University of Virginia | Conditions: Coronary Artery Disease | Status: COMPLETED